124 related articles for article (PubMed ID: 23766477)
21. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion.
Murakami T; Takagi H; Kita M; Nishiwaki H; Miyamoto K; Ohashi H; Watanabe D; Yoshimura N
Am J Ophthalmol; 2006 Aug; 142(2):318-20. PubMed ID: 16876516
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Retinal Vein Bypass Surgery in a Porcine Model.
Shen LJ; Chen YQ; Cheng D; Zhang C; Jiang L; Hong M; Kang QY
Curr Eye Res; 2016; 41(1):79-87. PubMed ID: 25549290
[TBL] [Abstract][Full Text] [Related]
23. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
24. Cytokine Levels in Experimental Branch Retinal Vein Occlusion Treated With Either Bevacizumab or Triamcinolone Acetonide.
McAllister IL; Vijayasekaran S; McLenachan S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; Yu DY
Transl Vis Sci Technol; 2024 Jun; 13(6):13. PubMed ID: 38899953
[TBL] [Abstract][Full Text] [Related]
25. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone intravitreal implant downregulates PDGFR-α and upregulates caveolin-1 in experimental branch retinal vein occlusion.
Cehofski LJ; Kruse A; Magnusdottir SO; Alsing AN; Nielsen JE; Kirkeby S; Honoré B; Vorum H
Exp Eye Res; 2018 Jun; 171():174-182. PubMed ID: 29505751
[TBL] [Abstract][Full Text] [Related]
27. Serum concentration of bevacizumab after intravitreal injection in experimental branch retinal vein occlusion.
Chuang LH; Wu WC; Yeung L; Wang NK; Hwang YS; Chen KJ; Kuo JZ; Lai CC
Ophthalmic Res; 2011; 45(1):31-5. PubMed ID: 20714188
[TBL] [Abstract][Full Text] [Related]
28. Effect of glial cell line-derived neurotrophic factor on retinal function after experimental branch retinal vein occlusion.
Ejstrup R; Cour Ml; Kyhn MV; Heegaard S; Kiilgaard JF
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6207-13. PubMed ID: 22915030
[TBL] [Abstract][Full Text] [Related]
29. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
30. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
van Overdam KA; Missotten T; Spielberg LH
Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological consequences of experimental branch retinal vein occlusion in pigs and the effect of dorzolamide.
Ejstrup R; Scherfig E; la Cour M
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):952-8. PubMed ID: 21051705
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
Lim JW
Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
[TBL] [Abstract][Full Text] [Related]
33. The Enhancing Effect of Focused Ultrasound on TNK-Tissue Plasminogen Activator-Induced Thrombolysis Using an In Vitro Circulating Flow Model.
Papadopoulos N; Yiallouras C; Damianou C
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2891-2899. PubMed ID: 27599905
[TBL] [Abstract][Full Text] [Related]
34. Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits.
Wu J; Zhou X; Hu Y; Zhang T; Ma Z; Li X; Su L; Wang J; Lin S
Retina; 2010 Jun; 30(6):966-70. PubMed ID: 20094009
[TBL] [Abstract][Full Text] [Related]
35. The vasodilatory effect of juxta-arteriolar microinjection of endothelinA receptor inhibitor in healthy and acute branch retinal vein occlusion minipig retinas.
Stangos AN; Petropoulos IK; Pournaras JA; Mendrinos E; Pournaras CJ
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2185-90. PubMed ID: 19875661
[TBL] [Abstract][Full Text] [Related]
36. Vasomotor effect of intravitreal juxta-arteriolar injection of L-lactate on the retinal arterioles after acute branch retinal vein occlusion in minipigs.
Mendrinos E; Petropoulos IK; Mangioris G; Tsilimbaris MK; Papadopoulou DN; Geka A; Pournaras CJ
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3215-20. PubMed ID: 21345988
[TBL] [Abstract][Full Text] [Related]
37. Neuronal degeneration and associated alterations in cytokine and protein in an experimental branch retinal venous occlusion model.
McAllister IL; Vijayasekaran S; Zhang D; McLenachan S; Chen FK; Yu DY
Exp Eye Res; 2018 Sep; 174():133-146. PubMed ID: 29803555
[TBL] [Abstract][Full Text] [Related]
38. Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment.
Kaneda S; Miyazaki D; Sasaki S; Yakura K; Terasaka Y; Miyake K; Ikeda Y; Funakoshi T; Baba T; Yamasaki A; Inoue Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2982-8. PubMed ID: 21273540
[TBL] [Abstract][Full Text] [Related]
39. Morphologic and functional changes in retinal vessels associated with branch retinal vein occlusion.
Muraoka Y; Tsujikawa A; Murakami T; Ogino K; Kumagai K; Miyamoto K; Uji A; Yoshimura N
Ophthalmology; 2013 Jan; 120(1):91-9. PubMed ID: 22980743
[TBL] [Abstract][Full Text] [Related]
40. Analysis of retinal nonperfusion using depth-integrated optical coherence tomography images in eyes with branch retinal vein occlusion.
Sakimoto S; Gomi F; Sakaguchi H; Akiba M; Kamei M; Nishida K
Invest Ophthalmol Vis Sci; 2015 Jan; 56(1):640-6. PubMed ID: 25574041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
